Which has the lower trailing P/E, EW or TEVA?

EW has the lower trailing P/E: EW trades at 51.70 and TEVA at 62.70. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, EW or TEVA?

Over the past five years, EW grew revenue faster — EW at a 5.75% CAGR versus TEVA at 1.19%.

Is EW or TEVA more profitable?

EW runs the higher net margin — EW at 15.43% versus TEVA at 4.08%.

How have EW and TEVA total returns compared?

Over the past 10 years, EW delivered 8.88% and TEVA delivered -2.70% annualized total return. Past performance doesn't predict future results.

Edwards Lifesciences Corporation (EW) vs Teva Pharmaceutical Industries Limited (TEVA)

A side-by-side comparison of Edwards Lifesciences Corporation and Teva Pharmaceutical Industries Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.

Edwards Lifesciences Corporation

$51.95B

$90.23HealthcareDelayed quote: Aug 28, 2026, 12:20 PM EDT

TEVA

Teva Pharmaceutical Industries Limited

$42.66B

$36.63HealthcareDelayed quote: Aug 28, 2026, 12:20 PM EDT

Total return — EW vs TEVA

growth of $100 · dividends reinvested · last 10y

EW +129.6% (+8.7%/yr)TEVA -23.4% (-2.6%/yr)EW compounded faster over this window

EW TEVA

EW vs TEVA: by the numbers

•EW is the larger company ($51.95B vs $42.66B market cap).
•EW trades at the lower trailing earnings multiple (51.70 vs 62.70 P/E), one valuation lens rather than an overall verdict.
•EW converts more revenue to profit (15.43% vs 4.08% net margin).
•EW grew revenue faster over the past five years (5.75% vs 1.19% CAGR).

Metrics side by side

Valuation

Metric	EW	TEVA
P/E ratio	51.70	62.70
Forward P/E	29.97	18.80
P/S ratio	7.98	2.57
P/B ratio	4.89	5.73
EV / EBITDA	24.94	19.40
FCF yield	2.76%	3.03%

Profitability

Metric	EW	TEVA
Gross margin	77.98%	52.47%
Operating margin	28.09%	11.45%
Net margin	15.43%	4.08%
ROE	9.46%	9.10%
ROIC	10.22%	6.79%

Growth (annualized)

Metric	EW	TEVA
Revenue CAGR (5Y)	5.75%	1.19%
EPS CAGR (5Y)	6.87%	N/A
FCF CAGR (5Y)	6.41%	14.58%
Total return CAGR (5Y)	-5.02%	32.11%

Frequently asked

Which has the lower trailing P/E, EW or TEVA?: EW has the lower trailing P/E: EW trades at 51.70 and TEVA at 62.70. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, EW or TEVA?: Over the past five years, EW grew revenue faster — EW at a 5.75% CAGR versus TEVA at 1.19%.
Is EW or TEVA more profitable?: EW runs the higher net margin — EW at 15.43% versus TEVA at 4.08%.
How have EW and TEVA total returns compared?: Over the past 10 years, EW delivered 8.88% and TEVA delivered -2.70% annualized total return. Past performance doesn't predict future results.

Go deeper

Full EW analysis Full TEVA analysis Interactive comparison tool

Dig into the metrics

Edwards Lifesciences P/E ratio Teva Pharmaceutical Industries P/E ratio Edwards Lifesciences ROE Teva Pharmaceutical Industries ROE Edwards Lifesciences operating margin Teva Pharmaceutical Industries operating margin Edwards Lifesciences revenue growth Teva Pharmaceutical Industries revenue growth Edwards Lifesciences free cash flow Teva Pharmaceutical Industries free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.